Marty Makary: “Today, the FDA is also announcing its plans to issue final…”

“I'm giving you real numbers that companies have shared with me on their costs. Lowered prices for Drug developed means, lower R and D costs and lower drug prices for everyday Americans. Today, the FDA is also announcing its plans to issue final guidance on interchangeability. something the Secretary just described, eliminating the bureaucratic switching studies that have been required. When a doctor prescribes a branded small molecule, the patient and their pharmacist can have that substitute it out for a generic small molecule.” (13:21–13:28)

This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.